These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 8934529

  • 1. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
    Aroca P, Mahadevan D, Santos E.
    Oncogene; 1996 Nov 07; 13(9):1839-46. PubMed ID: 8934529
    [Abstract] [Full Text] [Related]

  • 2. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B, DeBell KE, Graham L, Rellahan BL, Alava MA, Laborda J, Bonvini E.
    J Immunol; 1998 Feb 01; 160(3):1059-66. PubMed ID: 9570517
    [Abstract] [Full Text] [Related]

  • 3. Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.
    Browaeys-Poly E, Cailliau K, Vilain JP.
    Eur J Biochem; 2000 Oct 01; 267(20):6256-63. PubMed ID: 11012680
    [Abstract] [Full Text] [Related]

  • 4. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways.
    Roche S, McGlade J, Jones M, Gish GD, Pawson T, Courtneidge SA.
    EMBO J; 1996 Sep 16; 15(18):4940-8. PubMed ID: 8890167
    [Abstract] [Full Text] [Related]

  • 5. Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes.
    Chuang LM, Hausdorff SF, Myers MG, White MF, Birnbaum MJ, Kahn CR.
    J Biol Chem; 1994 Nov 04; 269(44):27645-9. PubMed ID: 7961682
    [Abstract] [Full Text] [Related]

  • 6. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA, Lienhard GE, Lavan BE.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):487-92. PubMed ID: 9642156
    [Abstract] [Full Text] [Related]

  • 7. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
    Chung DL, Brandt-Rauf P, Murphy RB, Nishimura S, Yamaizumi Z, Weinstein IB, Pincus MR.
    Anticancer Res; 1991 Jun 18; 11(4):1373-8. PubMed ID: 1746893
    [Abstract] [Full Text] [Related]

  • 8. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
    Najib S, Sánchez-Margalet V.
    J Cell Biochem; 2002 Jun 18; 86(1):99-106. PubMed ID: 12112020
    [Abstract] [Full Text] [Related]

  • 9. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
    Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ.
    Nature; 1996 Feb 08; 379(6565):560-4. PubMed ID: 8596638
    [Abstract] [Full Text] [Related]

  • 10. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
    Pei Z, Maloney JA, Yang L, Williamson JR.
    Arch Biochem Biophys; 1997 Sep 01; 345(1):103-10. PubMed ID: 9281317
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F, Bonnec G, Tardivel A, Boujard D.
    Dev Biol; 1997 Aug 01; 188(1):122-33. PubMed ID: 9245517
    [Abstract] [Full Text] [Related]

  • 12. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
    Gupta RW, Mayer BJ.
    Oncogene; 1998 Oct 29; 17(17):2155-65. PubMed ID: 9811447
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A.
    J Mol Biol; 2002 Feb 01; 315(5):1167-77. PubMed ID: 11827484
    [Abstract] [Full Text] [Related]

  • 14. Biological activity of p27kip1 and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes.
    Font de Mora J, Uren A, Heidaran M, Santos E.
    Oncogene; 1997 Nov 20; 15(21):2541-51. PubMed ID: 9399642
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC, Oh WK, Kim BY, Kang DO, Kim MS, Heo GY, Ahn JS.
    Planta Med; 2003 Jul 20; 69(7):642-6. PubMed ID: 12898421
    [Abstract] [Full Text] [Related]

  • 16. Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor.
    Tang J, Feng GS, Li W.
    Oncogene; 1997 Oct 09; 15(15):1823-32. PubMed ID: 9362449
    [Abstract] [Full Text] [Related]

  • 17. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC.
    J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716
    [Abstract] [Full Text] [Related]

  • 18. SH2 domain specificity and activity modified by a single residue.
    Marengere LE, Songyang Z, Gish GD, Schaller MD, Parsons JT, Stern MJ, Cantley LC, Pawson T.
    Nature; 1994 Jun 09; 369(6480):502-5. PubMed ID: 7515480
    [Abstract] [Full Text] [Related]

  • 19. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW, Xiao S, Pillay TS, Kolch W, Olefsky JM.
    Oncogene; 1998 Aug 20; 17(7):889-99. PubMed ID: 9780005
    [Abstract] [Full Text] [Related]

  • 20. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
    Saucier C, Papavasiliou V, Palazzo A, Naujokas MA, Kremer R, Park M.
    Oncogene; 2002 Mar 14; 21(12):1800-11. PubMed ID: 11896612
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.